Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Hodgkin Disease 21Lymphoma 13Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Urinary Bladder Neoplasms 5Testicular Neoplasms 3Prostatic Neoplasms 3Melanoma 3Urethral Neoplasms 2Testicular Germ Cell Tumor 2Teratoma 2Lymphoma, Large-Cell, Anaplastic 2Uterine Cervical Neoplasms 1Skin Neoplasms 1Seminoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Lymphoma, Large B-Cell, Diffuse 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Leukemia 1Endodermal Sinus Tumor 1Carcinoma, Embryonal 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 17Radiotherapy 13Paclitaxel 13Cisplatin 9Vinorelbine 5Pemetrexed 5Gemcitabine 5Docetaxel 5Mastectomy, Segmental 4Gefitinib 4Bevacizumab 4Taxes 3Radiation 3Etoposide 3ceritinib 2shark cartilage extract 1pembrolizumab 1pegfilgrastim 1lorlatinib 1lazertinib 1efaproxiral 1Vindesine 1Vinblastine 1Tirapazamine 1Therapeutics 1Thalidomide 1Surgical Procedures, Operative 1Nivolumab 1Neoadjuvant Therapy 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Adenocarcinoma of Lung × Vinblastine × Clear all
NCT00002823 2013-03-28

Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed
3,300 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡